With the increasing application of regenerative medicine *in vivo*, non-invasive and accurate methods for estimating the white matter axons in neuronal tissue have become increasingly important. As a non-invasive method for patients, magnetic resonance (MR) imaging has demonstrated potential as a promising tool for evaluating axons *in vivo*. In particular, diffusion-weighted MR imaging (dMRI) and its applications, such as white matter tractography and the metrics derived from dMRI data (*i.e*., mean diffusivity and fractional anisotropy (FA)), have been used for the semi-quantitative measurement of normal and diseased axons of neuronal tissues, particularly in neurodegenerative diseases such as Alzheimer\'s disease, Parkinson\'s disease, and idiopathic normal pressure hydrocephalus (iNPH), because the diagnosis and monitoring of the status of neurodegenerative diseases are usually estimated based on clinical symptoms, gene abnormalities and imaging findings. Moreover, recent advances in MR imaging, such as more complicated and dedicated dMRI analyses, are emerging and can be compared with conventional dMRI. Unlike the previous conventional dMRI, recent advances in dMRI are based on the theory of the non-Gaussian assumption of water molecule diffusivity and/or compartment model analysis because the Gaussian assumption of water molecule diffusion in the tissue made by conventional dMRI theory has drawbacks and limitations that restrict the more accurate estimation of the microstructures of actual neuronal tissues. In actual neuronal tissues, Gaussian distributions of water molecules are rarely observed because tissue microstructures, such as cell membranes, organelles and myelin sheaths, can act as barriers to water molecules. Therefore, emerging and advanced dMRI analyses have the potential to provide new and additional information regarding the actual neuronal tissue microstructures compared with conventional dMRI.

iNPH is among the several types of neurodegenerative diseases. iNPH is a disease of unknown etiology, and its major triad of symptoms consists of gait disturbance, dementia and bladder incontinence. A characteristic feature of iNPH is that its symptoms can be relieved by a neurosurgical operation that drains excess cerebrospinal fluid (CSF), which is not the case for most neurodegenerative disorders. An improvement of symptoms is observed in patients with iNPH following shunt surgery, but the mechanism and origin of the symptoms of iNPH still require clarification. For example, the decreased excess CSF is not the only reason for improvement because some patients' symptoms improve without a marked change in the dilated ventricles after shunt surgery. In a more complicated scenario, microstructural changes in the neuronal tissue may be the cause of the symptoms. Applying advanced dMRI for iNPH patients is expected to provide additional and substantive information.

Diffusion kurtosis imaging (DKI) is an advanced dMRI technique that accesses the non-Gaussianity of water molecule displacement as a dimensionless metric, such as the mean kurtosis (MK). In iNPH patients, both the FA and MK are correlated with cognitive impairment, especially in the frontal lobe white matter; however, the MK may be superior for evaluating the changes in the subcortical white matter (Kamiya et al., 2016). Moreover, because it measures directionally specific kurtosis, DKI was found to potentially offer a more comprehensive and sensitive detection of tissue microstructural changes in a rodent maturation study (Cheung et al., 2009). Another dMRI analysis used the recently introduced MR technique of neurite orientation dispersion and density imaging (NODDI) to examine brain tissue using a three-compartment model that consisted of the intra-cellular component of restricted water, which indicates structures such as axons; the hindered extra-cellular water, which indicates structures such as glia; and the free (Gaussian-distributed) water of the CSF (Zhang et al., 2012). This technique can effectively evaluate the neurite abnormalities in the corticospinal tract (CST) in the brain, which are closely related to the symptom of gait disturbance in iNPH patients (Irie et al., 2017).

Q-space imaging (QSI) has also been introduced as an advanced dMRI technique for research and clinical purposes. This dMRI technique does not assume a predefined shape of the probability density function (PDF) for the diffusion displacement of the water molecules. In other words, whether the distribution of water molecules is Gaussian is not problematic for QSI measurements. Briefly, in QSI, the PDF of molecular water diffusion displacement is obtained by means of a Fourier transform of the measured diffusion echo attenuation of the dMRI data, and the full-width at half-maximum (FWHM) of the displacement PDF correlates with the localized space between barriers, including the cell membrane and/or myelin sheaths, in neuronal tissues *in vivo*. Therefore, QSI has the potential to provide microstructural information about neuronal tissues, including the cell compartment size and axon diameter. However, the precise assessment of axonal architecture using the QSI technique usually requires high gradient amplitudes in the MR imaging system, which are not safe for humans, and long scanning times (\~several hours), which are not realistic for *in vivo* human studies or clinical use. As an alternative method for analyzing QSI data, a two-component low-*q* fit model has been proposed. This model fits the measured echo attenuation at only the low *q*-values to extract the root mean square displacement of the water molecule diffusion. High-performance MR imaging systems with high gradient amplitudes are not needed for this approach. Moreover, good correlations between the metrics derived from two-component low-*q* fit QSI data and pathologic data related to axon diameters in excised mouse spinal cords have been reported in the literature (Ong and Wehrli, 2010). However, these authors scanned the excised spinal cords of pigs for 5 hours, which is not suitable for clinical applications. Using this approach with optimized imaging parameters to achieve a reasonable scanning time in a clinical MR scanner, one study that utilized QSI analysis with the two-component low-*q* fit model found that iNPH patients exhibited a significant increase in the intra-axonal volume fraction in the CST at the paraventricular level, but no significant difference was observed in the axon diameter compared with the normal controls (Kamiya et al., 2014). Another study using the same technique reported that the extracellular space of the posterior limb of the internal capsule (PLIC) was significantly higher than that in the same patients after lumboperitoneal shunt surgery, and no significant differences were observed in the PLIC axon diameters among the normal controls or in the patients before and after surgery (Hori et al., 2016) ([**Figure 1**](#F1){ref-type="fig"}).
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These are very interesting and important findings regarding *in vivo* axons and their surrounding structures. In patients with iNPH, past investigations suggest that compression and stretching of the white matter tracts of the CST may be the cause of reliable gait disturbance (Nakanishi et al., 2013). After neurosurgical procedures, such as lumboperitoneal shunt surgery, the symptoms soon improve in some patients with iNPH. Therefore, it was expected that irreversible structural damage was not directly observed in the axons and that microstructural changes, including narrowing of the peri-axonal space (extracellular space), accounted for the symptom. The results of the above two example studies support this hypothesis. Additionally, the extracellular space in patients with iNPH before treatment is wider than that in normal controls and significantly narrower than that in patients after shunt surgery (Hori et al., 2016). These findings may indicate that the cause of iNPH is partially explained by an inefficiency of the extracellular outflow pathway of the CSF in the extracellular space that includes the venous side of the glymphatic system, which might be developed as a parallel pathway for CSF resorption and exit from the ventricles in patients with iNPH (Bradley, 2015).

There are still several limitations to the application of advanced dMRI to the investigation of white matter axons *in vivo*. First, dMRI techniques generally require more time for data acquisition compared with conventional diffusion-weighted imaging (DWI). Additionally, much more time will be needed for images with higher spatial resolutions. In clinical settings, routine DWI only requires 1 minute or less for data acquisition, whereas advanced dMRI requires more than twice as much time. However, MR scanning times can shortened depending on the MR imaging technique; for example, the parallel imaging and simultaneous multi-slice techniques have been used over the past several years. Therefore, from a technical perspective, the long acquisition time of advanced dMRI will be solved by progress in the software and hardware of MR imaging systems in the near future. As a second limitation, although the diffusion metrics have potential as imaging biomarkers for investigating axons *in vivo*, reproducibility is a concern because the MR imaging signal produces a relative value. There are several factors that could be problematic for image reproducibility, such as differences between MR scanner venders, models, imaging parameters and software (including sequence designs), in all types of advanced and conventional dMRI. For example, the *b*-value dependences on diffusion tensor imaging (DTI) quantitation and the sensitivity of detecting neural tissue changes have been reported (Hui et al., 2010). Therefore, caution must be taken when interpreting dMRI metrics, and confirmation of the reliability and standardization of imaging techniques for advanced dMRI must be established for imaging biomarkers of axons *in vivo*.

Despite the numerous limitations mentioned above, advanced dMRI, especially QSI, has the potential to non-invasively provide novel information about axons *in vivo* and will be a necessary tool for research and clinical use. The microstructural changes of axons and peri-axonal tissues can be directly measured as quantitative values with advanced dMRI techniques; *e.g*., axon diameters can be measured *in vivo*. These advances indicate that the monitoring of axons in patients is possible and will provide a powerful support tool for managing patients with degenerative diseases and for examining degenerative and regenerative processes.
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